Dr. Shaheryar Shafi is an interdisciplinary biomedical researcher working at the interface of cancer biology, inflammation, tumor immunity, and computational biology. With academic training spanning microbiology, basic medicine, and biological sciences, he brings a broad biomedical perspective to research on how inflammatory signaling, immune-cell behavior, metabolism, and the tumor microenvironment influence cancer initiation, progression, and therapeutic response.
His research spans glioblastoma, colorectal cancer, breast cancer, inflammatory bowel disease, ferroptosis, and cancer diagnostics. He integrates experimental approaches with transcriptomic and single-cell analyses to examine molecular heterogeneity and identify biologically meaningful mechanisms in complex disease contexts.
Dr. Shafi’s research interests include tumor-associated macrophages, efferocytosis, immune microenvironments, and the translation of complex biological findings into clinically relevant insights. He also has experience in academic writing, editorial support, and science communication, making advanced biomedical research accessible to scientific and clinical audiences.
He is affiliated with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (SIBET-CAS), and the University of Science and Technology of China (USTC).
Dr. Shaheryar Shafi is an interdisciplinary biomedical researcher working at the interface of cancer biology, inflammation, tumor immunity, and computational biology. With academic training spanning microbiology, basic medicine, and biological sciences, he brings a broad biomedical perspective to research on how inflammatory signaling, immune-cell behavior, metabolism, and the tumor microenvironment influence cancer initiation, progression, and therapeutic response.
His research spans glioblastoma, colorectal cancer, breast cancer, inflammatory bowel disease, ferroptosis, and cancer diagnostics. He integrates experimental approaches with transcriptomic and single-cell analyses to examine molecular heterogeneity and identify biologically meaningful mechanisms in complex disease contexts.
Dr. Shafi’s research interests include tumor-associated macrophages, efferocytosis, immune microenvironments, and the translation of complex biological findings into clinically relevant insights. He also has experience in academic writing, editorial support, and science communication, making advanced biomedical research accessible to scientific and clinical audiences.
He is affiliated with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (SIBET-CAS), and the University of Science and Technology of China (USTC).